KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $2.5 million.

  • Pacific Biosciences Of California's Depreciation and Depletion fell 4130.69% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 592.33%. This contributed to the annual value of $13.8 million for FY2024, which is 2000.0% up from last year.
  • Pacific Biosciences Of California's Depreciation and Depletion amounted to $2.5 million in Q3 2025, which was down 4130.69% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Depreciation and Depletion ranged from a high of $5.1 million in Q1 2025 and a low of $1.6 million during Q2 2021
  • Over the past 5 years, Pacific Biosciences Of California's median Depreciation and Depletion value was $2.7 million (recorded in 2025), while the average stood at $2.8 million.
  • Over the last 5 years, Pacific Biosciences Of California's Depreciation and Depletion had its largest YoY gain of 5836.42% in 2025, and its largest YoY loss of 4130.69% in 2025.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Depreciation and Depletion stood at $2.3 million in 2021, then increased by 13.56% to $2.6 million in 2022, then rose by 17.56% to $3.0 million in 2023, then decreased by 4.81% to $2.9 million in 2024, then decreased by 14.19% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $2.7 million for Q2 2025, and $5.1 million during Q1 2025.